Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Humacyte Inc
HUMACurrent price
4.84 USD
-0.075 USD (-1.53%)
Last closed
5.34 USD
Company
www.humacyte.com
ISIN
US44486Q1031
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
724 378 496 USD
Yield for 12 month
+98.16 %
1Y
3Y
5Y
10Y
15Y
HUMA
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina. Address: 2525 East North Carolina Highway 54, Durham, NC, United States, 27713
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+1 565 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-76 550 000 USD
Last Year
-6 690 000 USD
Current Quarter
–
Last Quarter
-1 823 000 USD
Key Figures HUMA
1 year
3 years
5 years
10 years
EBITDA
-102 215 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-51.76 %
PEG Ratio
–
Return On Equity TTM
-850.81 %
Wall Street Target Price
13 USD
Revenue TTM
–
Book Value
-0.53 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
1 565 000 USD
Earnings per share
-1.27 USD
Diluted Eps TTM
-1.27 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics HUMA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HUMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation HUMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
153.9075
Enterprise Value EBITDA
4.3389
Price Book MRQ
30.2811
Financials HUMA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HUMA
For 52 weeks
2.25 USD
9.97 USD
50 Day MA
5.46 USD
Shares Short Prior Month
16 028 146
200 Day MA
5.33 USD
Short Ratio
6.18
Shares Short
16 675 340
Short Percent
17.28 %
BeatStart